New stomach bug treatment shows promise in 14-Day trial

NCT ID NCT06682533

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well a 14-day course of tegoprazan (a stomach acid reducer) combined with two antibiotics works to clear H. pylori infection. About 200 adults who need a stomach scope will take the treatment, and researchers will check if the bacteria are gone using a breath test. The goal is to see if this approach is effective and tolerable, especially when adding bismuth to boost success rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for H.PYLORI INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Helicobacter pylori infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Digestive Disease Center, Soonchunhyang University Hospital

    RECRUITING

    Seoul, 04401, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••